Cargando…
Leptomeningeal carcinomatosis in non-small-cell lung cancer: initial response to erlotinib followed by relapse despite continuing radiological resolution of disease
A 60-year-old male was diagnosed with T3, N3, M1b epidermal growth factor receptor (EGFR) mutant lung adenocarcinoma. Five months later he developed significant headaches, weakness and numbness of the left leg, and unsteadiness of gait. Magnetic resonance imaging (MRI) brain demonstrated subtle gyra...
Autores principales: | Lee, Alvin J. X., Benamore, Rachel, Hofer, Monika, Chitnis, Meenali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015419/ https://www.ncbi.nlm.nih.gov/pubmed/27617103 http://dx.doi.org/10.1093/omcr/omw069 |
Ejemplares similares
-
Pulsed Erlotinib as Sole Treatment of Leptomeningeal Carcinomatosis: Can We Avoid the Use of Intrathecal Therapy?
por: Santhosh-Kumar, Cheruppolil R., et al.
Publicado: (2014) -
Stroke secondary to leptomeningeal carcinomatosis with radiologic signs of arterial invasion
por: Gutiérrez, María López, et al.
Publicado: (2022) -
Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
por: Uruga, Hironori, et al.
Publicado: (2018) -
Central retinal vein occlusion as the initial presentation in leptomeningeal carcinomatosis
por: Venkataraman, Anusha, et al.
Publicado: (2016) -
Complete Eye Ophthalmoplegia: the unusual initial presentation of Leptomeningeal Carcinomatosis
por: Chauhan, Lakshpaul, et al.
Publicado: (2019)